TY - JOUR
T1 - Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
AU - Pontone, Gregory M.
AU - Dissanayka, Nadeeka
AU - Apostolova, Liana
AU - Brown, Richard G.
AU - Dobkin, Roseanne
AU - Dujardin, Kathy
AU - Friedman, Joseph H.
AU - Leentjens, Albert F.G.
AU - Lenze, Eric J.
AU - Marsh, Laura
AU - Mari, Lynda
AU - Monchi, Oury
AU - Richard, Irene H.
AU - Schrag, Anette
AU - Strafella, Antonio P.
AU - Vernaleo, Beth
AU - Weintraub, Daniel
AU - Mari, Zoltan
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Anxiety is a severe problem for at least one-third of people living with Parkinson’s disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high prevalence and impact on daily life, anxiety is often undiagnosed and untreated. To better address anxiety in PD, future research must improve knowledge about the mechanism of anxiety in PD and address the lack of empirical evidence from clinical trials. In response to these challenges, the Parkinson’s Foundation sponsored an expert meeting on anxiety on June 13th and 14th 2018. This paper summarizes the findings from that meeting informed by a review of the existing literature and discussions among patients, caregivers, and an international, clinician-scientist, expert panel working group. The goal is to provide recommendations to improve our understanding and treatment of anxiety in PD.
AB - Anxiety is a severe problem for at least one-third of people living with Parkinson’s disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high prevalence and impact on daily life, anxiety is often undiagnosed and untreated. To better address anxiety in PD, future research must improve knowledge about the mechanism of anxiety in PD and address the lack of empirical evidence from clinical trials. In response to these challenges, the Parkinson’s Foundation sponsored an expert meeting on anxiety on June 13th and 14th 2018. This paper summarizes the findings from that meeting informed by a review of the existing literature and discussions among patients, caregivers, and an international, clinician-scientist, expert panel working group. The goal is to provide recommendations to improve our understanding and treatment of anxiety in PD.
UR - http://www.scopus.com/inward/record.url?scp=85078628261&partnerID=8YFLogxK
U2 - 10.1038/s41531-019-0102-8
DO - 10.1038/s41531-019-0102-8
M3 - Review article
AN - SCOPUS:85078628261
SN - 2373-8057
VL - 5
JO - npj Parkinson's Disease
JF - npj Parkinson's Disease
IS - 1
M1 - 30
ER -